Author(s):
R. V. Khankari, S. M. Umale, A. S. Patil, T. R. Thanekar
Email(s):
rupaliwani44@gmail.com
DOI:
10.52711/2231-5659.2023.00010 
Address:
R. V. Khankari, S. M. Umale, A. S. Patil, T. R. Thanekar
Prof. Ravindra Nikam College of Pharmacy, Gondur, Dhule.
*Corresponding Author
Published In:
Volume - 13,
Issue - 1,
Year - 2023
ABSTRACT:
The human monkeypox is an emerging zoonotic orthopoxvirus with a clinical presentation similar to that of smallpox. It is difficult to differentiate monkeypox from other orthopedic infections, and laboratory diagnosis is the primary component of disease identification and monitoring. However, current diagnostics are time-consuming, and new tests are needed for rapid and precise diagnosis. Most cases have been reported in Central Africa; however, an increasing number of cases have been reported in Europe, the United States of America (USA), Australia, and the United Arab Emirates. Although investigation of the current global outbreak is still ongoing, viral transmission seems to have occurred during crowded events in Spain and Belgium. New therapeutics and vaccines are being deployed for the treatment and prevention of monkeypox, and more research on the epidemiology, biology, and ecology of the virus in endemic areas is required to understand and prevent further global outbreaks.
Cite this article:
R. V. Khankari, S. M. Umale, A. S. Patil, T. R. Thanekar. A Review on Human Monkeypox Virus. Asian Journal of Research in Pharmaceutical Sciences. 2023; 13(1):56-2. doi: 10.52711/2231-5659.2023.00010
Cite(Electronic):
R. V. Khankari, S. M. Umale, A. S. Patil, T. R. Thanekar. A Review on Human Monkeypox Virus. Asian Journal of Research in Pharmaceutical Sciences. 2023; 13(1):56-2. doi: 10.52711/2231-5659.2023.00010 Available on: https://ajpsonline.com/AbstractView.aspx?PID=2023-13-1-10
REFERENCES:
1. Sklenovská N, Van Ranst M. Emergence of monkeypox as the most important orthopoxvirus infection in humans. Front Public Health. 2018;6:241.
2. Jezek Z, Marennikova SS, Mutumbo M, et al. Human monkeypox: a study of 2,510 contacts of 214 patients. J Infect Dis. 1986;154:551–5.
3. Huhn GD, Bauer AM, Yorita K, et al. Clinical characteristics of human monkeypox, and risk factors for severe disease. Clin Infect Dis. 2005;41:1742–51.
4. Durski KN, McCollum AM, Nakazawa Y, et al. Emergence of Monkeypox − West and Central Africa, 1970-2017. MMWR Morb Mortal Wkly Rep. 2018;67:306–10.
5. Di Giulio DB, Eckburg PB. Human monkeypox: an emerging zoonosis. Lancet Infect Dis. 2004;4:15–25.
6. McCollum AM, Damon IK. Human monkeypox. Clin Infect Dis. 2014;58:260–7.
7. Hutin YJ, Williams RJ, Malfait P, et al. Outbreak of human monkeypox, Democratic Republic of Congo, 1996 to 1997. Emerg Infect Dis. 2001;7:434–8
8. Likos AM, Sammons SA, Olson VA, et al. A tale of two clades: monkeypox viruses. J Gen Virol. 2005;86:2661–72.
9. Reynolds MG, Damon IK. Outbreaks of human monkeypox after cessation of smallpox vaccination. Trends Microbiol. 2012;20:80–7.
10. Yinka-Ogunleye A, Aruna O, Ogoina D, et al. Reemergence of Human Monkeypox in Nigeria, 2017. Emerg Infect Dis. 2018;24:1149–51.
11. Jezek Z, Szczeniowski M, Paluku KM, et al. Human monkeypox: clinical features of 282 patients. J Infect Dis. 1987;156:293–8.
12. Vaughan A, Aarons E, Astbury J, et al. Human-to-human transmission of monkeypox virus, United Kingdom, October 2018. Emerg Infect Dis. 2020;26:782–5.
13. Beer EM, Rao VB. A systematic review of the epidemiology of human monkeypox outbreaks and implications for outbreak strategy. PLoS Negl Trop Dis. 2019;13:e0007791.
14. Bunge EM, Hoet B, Chen L, Lienert F, Weidenthaler H, Baer LR, et al. The changing epidemiology of human monkeypox—A potential threat? A systematic review. PLoS Negl Trop Dis. 2022;16(2):e0010141. pmid:35148313
15. Hoff NA, Doshi RH, Colwell B, Kebela-Illunga B, Mukadi P, Mossoko M, et al. Evolution of a Disease Surveillance System: An Increase in Reporting of Human Monkeypox Disease in the Democratic Republic of the Congo, 2001–2013. Int J Trop Dis Health. 2017;25(2).
16. Fleischauer AT, Kile JC, Davidson M, Fischer M, Karem KL, Teclaw R, et al. Evaluation of Human-to-Human Transmission of Monkeypox from Infected Patients to Health Care Workers. Clin Infect Dis. 2005;40(5):689–694. pmid:15714414
17. CDC. African Rodent Importation Ban. 2015. Available from: https://www.cdc.gov/poxvirus/monkeypox/african-ban.html.
18. Adler H, Gould S, Hine P, Snell LB, Wong W, Houlihan CF, et al. Clinical features and management of human monkeypox: a retrospective observational study in the UK. Lancet Infect Dis. 2022 May 24;0(0). pmid:35623380
19. (UKHSA) UHSA. Monkeypox cases confirmed in England–latest updates. 2022. Available from: https://www.gov.uk/government/news/monkeypox-cases-confirmed-in-england-latest-updates.
20. Bragazzi NL, Kong JD, Mahroum N, Tsigalou C, Khamisy-Farah R, Converti M, et al. Epidemiological trends and clinical features of the ongoing monkeypox epidemic: A preliminary pooled data analysis and literature review. J Med Virol. n/a(n/a).
21. BBC. More than 300 monkeypox cases now found in UK. 2022. Available from: https://www.bbc.com/news/health-61709659.
22. CDC. 2022 Monkeypox and Orthopoxvirus Outbreak Global Map. 2022. Available from: https://www.cdc.gov/poxvirus/monkeypox/response/2022/world-map.html.
23. WHO. Multi-country monkeypox outbreak: situation update. 2022. Available from: https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON390#:~:text=Outbreak%20at%20a%20glance,Epidemiological%20investigations%20are%20ongoing.
24. Nolen LD, Osadebe L, Katomba J, Likofata J, Mukadi D, Monroe B, et al. Introduction of Monkeypox into a Community and Household: Risk Factors and Zoonotic Reservoirs in the Democratic Republic of the Congo. Am J Trop Med Hyg. 2015;93(2):410–415. pmid:26013374
25. Reynolds MG, Davidson WB, Curns AT, Conover CS, Huhn G, Davis JP, et al. Spectrum of infection and risk factors for human monkeypox, United States, 2003. Emerg Infect Dis. 2007 Sep;13(9):1332–1339. pmid:18252104
26. Cohen J. Concern grows that human monkeypox outbreak will establish virus in animals outside Africa. 2022. Available from: https://www.science.org/content/article/concern-grows-human-monkeypox-outbreak-will-establish-virus-animals-outside-africa.
27. ECDC. Monkeypox: ECDC publishes rapid risk assessment. 2022. Available from: https://www.efsa.europa.eu/en/news/monkeypox-ecdc-publishes-rapid-risk-assessment.
28. CDC. Isolation and Infection Control: Home. 2022. Available from: https://www.cdc.gov/poxvirus/monkeypox/clinicians/infection-control-home.html.
29. CDC. Potential exposure to person with confirmed human monkeypox infection—United States. 2021. Available from: https://emergency.cdc.gov/han/2021/han00446.asp.
30. Learned LA, Reynolds MG, Wassa DW, Li Y, Olson VA, Karem K, et al. Extended interhuman transmission of monkeypox in a hospital community in the Republic of the Congo, 2003. Am J Trop Med Hyg. 2005;73(2):428–434. pmid:16103616
31. Human monkeypox—Kasai Oriental, Democratic Republic of Congo, February 1996-October 1997. MMWR Morb Mortal Wkly Rep. 1997 Dec 12;46(49):1168–1171.
32. Sklenovská N, Van Ranst M. Emergence of Monkeypox as the Most Important Orthopoxvirus Infection in Humans. Front Public Health. 2018:2018-September-04;6.
33. WHO. Multi-country monkeypox outbreak: situation update. 2022 [cited 2022 Jul 14]. Available from: https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON393.
34. Africa W. Weekly Bulletin on Outbreaks and Other Emergencies. 2017 20/10/2017. Report No.
35. Vivancos R, Anderson C, Blomquist P, Balasegaram S, Bell A, Bishop L, et al. Community transmission of monkeypox in the United Kingdom, April to May 2022. Eurosurveillance. 2022;27(22):2200422. pmid:35656834
36. Girometti N, Byrne R, Bracchi M, Heskin J, McOwan A, Tittle V, et al. Demographic and clinical characteristics of confirmed human monkeypox virus cases in individuals attending a sexual health centre in London, UK: an observational analysis. Lancet Infect Dis. 2022 Jul 1. pmid:35785793
37. Jenness SM, Begier EM, Neaigus A, Murrill CS, Wendel T, Hagan H. Unprotected anal intercourse and sexually transmitted diseases in high-risk heterosexual women. Am J Public Health. 2011 Apr;101(4):745–750. pmid:20558790
38. McCollum AM, Damon IK. Human Monkeypox. Clin Infect Dis. 2013;58(2):260–267. pmid:24158414
39. Damon IK. Status of human monkeypox: clinical disease, epidemiology and research. Vaccine. 2011 Dec 30;29(Suppl 4):D54–D59. pmid:22185831
40. Kalthan E, Tenguere J, Ndjapou SG, Koyazengbe TA, Mbomba J, Marada RM, et al. Investigation of an outbreak of monkeypox in an area occupied by armed groups, Central African Republic. Med Mal Infect. 2018 Jun;48(4):263–268. pmid:29573840
41. Harris E. What to Know About Monkeypox. JAMA. 2022;327(23):2278–2279. pmid:35622356
42. de Nicolas-Ruanes B, Vivancos MJ, Azcarraga-Llobet C, Moreno AM, Rodriguez-Dominguez M, Berna-Rico ED, et al. Monkeypox virus case with maculopapular exanthem and proctitis during the Spanish outbreak in 2022. J Eur Acad Dermatol Venereol. 2022;36(8). pmid:35675097
43. Antinori A, Mazzotta V, Vita S, Carletti F, Tacconi D, Lapini LE, et al. Epidemiological, clinical and virological characteristics of four cases of monkeypox support transmission through sexual contact, Italy, May 2022. Eurosurveillance. 2022;27(22):2200421.
44. Murphy S. Monkeypox Br Dent J. 2022 Jun;232(11):760.
45. Benites-Zapata V, Ulloque-Badaracco J, Alarcon-Braga E, Hernandez-Bustamante E, Mosquera M, Bonilla-Aldana D, et al. Clinical Features, Hospitalisation and Deaths associated with Monkeypox: A systematic review and meta-analysis 2022.
46. Li Y, Olson VA, Laue T, Laker MT, Damon IK. Detection of monkeypox virus with real-time PCR assays. J Clin Virol. 2006 Jul;36(3):194–203. pmid:16731033
47. Shchelkunov SN, Shcherbakov DN, Maksyutov RA, Gavrilova EV. Species-specific identification of variola, monkeypox, cowpox, and vaccinia viruses by multiplex real-time PCR assay. J Virol Methods. 2011 Aug;175(2):163–169. pmid:21635922
48. Kulesh DA, Loveless BM, Norwood D, Garrison J, Whitehouse CA, Hartmann C, et al. Monkeypox virus detection in rodents using real-time 3′-minor groove binder TaqMan® assays on the Roche LightCycler. Lab Invest. 2004;84(9):1200–1208. pmid:15208646
49. CDC. Test Procedure: Monkeypox virus Generic Real-Time PCR Test. 2022. Available from: https://www.cdc.gov/poxvirus/monkeypox/pdf/PCR-Diagnostic-Protocol-508.pdf.
50. Karem KL, Reynolds M, Braden Z, Lou G, Bernard N, Patton J, et al. characterization of acute-phase humoral immunity to monkeypox: use of immunoglobulin M enzyme-linked immunosorbent assay for detection of monkeypox infection during the 2003 North American outbreak. Clin Diagn Lab Immunol. 2005;12(7):867–872. pmid:16002637
51. Townsend MB, MacNeil A, Reynolds MG, Hughes CM, Olson VA, Damon IK, et al. Evaluation of the Tetracore Orthopox BioThreat® antigen detection assay using laboratory grown orthopoxviruses and rash illness clinical specimens. J Virol Methods. 2013 Jan;187(1):37–42. pmid:22981983
52. Kitamoto N, Kobayashi T, Kato Y, Wakamiya N, Ikuta K, Tanaka T, et al. Preparation of monoclonal antibodies cross-reactive with orthopoxviruses and their application for direct immunofluorescence test. Microbiol Immunol. 2005;49(3):219–225. pmid:15781995
53. CDC. Laboratory Procedures and Biosafety Guidelines. 2022. Available from: https://www.cdc.gov/poxvirus/monkeypox/lab-personnel/lab-procedures.html#:~:text=Culture%2Dbased%20testing%20for%20monkeypox,and%20BSL%2D3%20containment%20facilities.
54. Grosenbach DW, Honeychurch K, Rose EA, Chinsangaram J, Frimm A, Maiti B, et al. Oral Tecovirimat for the Treatment of Smallpox. N Engl J Med. 2018 Jul 5;379(1):44–53. pmid:29972742
55. Chittick G, Morrison M, Brundage T, Nichols WG. Short-term clinical safety profile of brincidofovir: A favorable benefit-risk proposition in the treatment of smallpox. Antiviral Res. 2017 Jul;143:269–277. pmid:28093339
56. FDA. FDA approves drug to treat smallpox. 2021. Available from: https://www.fda.gov/drugs/drug-safety-and-availability/fda-approves-drug-treat-smallpox.
57. Vora S, Damon I, Fulginiti V, Weber SG, Kahana M, Stein SL, et al. Severe eczema vaccinatum in a household contact of a smallpox vaccinee. Clin Infect Dis. 2008 May 15;46(10):1555–1561. pmid:18419490
58. Lindholm DA, Fisher RD, Montgomery JR, Davidson W, Yu PA, Yu YC, et al. Preemptive Tecovirimat Use in an Active Duty Service Member Who Presented With Acute Myeloid Leukemia After Smallpox Vaccination. Clin Infect Dis. 2019 Nov 27;69(12):2205–2207. pmid:30959520
59. Heymann DL, Szczeniowski M, Esteves K. Re-emergence of monkeypox in Africa: a review of the past six years. Br Med Bull. 1998;54(3):693–702. pmid:10326294
60. Hammarlund E, Lewis MW, Carter SV, Amanna I, Hansen SG, Strelow LI, et al. Multiple diagnostic techniques identify previously vaccinated individuals with protective immunity against monkeypox. Nat Med. 2005 Sep;11(9):1005–1011. pmid:16086024
61. Rimoin AW, Mulembakani PM, Johnston SC, Lloyd Smith JO, Kisalu NK, Kinkela TL, et al. Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo. Proc Natl Acad Sci U S A. 2010 Sep 14;107(37):16262–16267. pmid:20805472
62. WHO. Vaccines and immunization for monkeypox: Interim guidance, 14 June 2022. 2022. Available from: https://www.who.int/publications/i/item/who-mpx-immunization-2022.1.
63. Petersen E, Zumla A, Hui DS, Blumberg L, Valdoleiros SR, Amao L, et al. Vaccination for monkeypox prevention in persons with high-risk sexual behaviours to control on-going outbreak of monkeypox virus clade 3. Int J Infect Dis. pmid:35788415
64. CDC. Monkeypox and Smallpox Vaccine Guidance. 2022. Available from: https://www.cdc.gov/poxvirus/monkeypox/clinicians/smallpox-vaccine.html.
65. Costello V, Sowash M, Gaur A, Cardis M, Pasieka H, Wortmann G, et al. Imported Monkeypox from International Traveler, Maryland, USA, 2021. Emerg Infect Dis 2022;28(5):1002–1005. pmid:35263559
66. Fv Rheinbaben, Gebel J, Exner M, Schmidt A. Environmental resistance, disinfection, and sterilization of poxviruses. In: Mercer AA, Schmidt A, Weber O, editors. Poxviruses. Basel: Birkhäuser Basel; 2007. p. 397–405.
67. (PHE) PHE. Monkeypox: Guidance for environmental cleaning and decontamination. 2018. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1079779/Monkeypox_Guidance__cleaning_decontamination.pdf.
68. CDC. Monitoring People Who Have Been Exposed. 2022 [cited 2022 Jul 17]. Available from: https://www.cdc.gov/poxvirus/monkeypox/clinicians/monitoring.html.
69. Ayouni I, Maatoug J, Dhouib W, Zammit N, Fredj SB, Ghammam R, et al. Effective public health measures to mitigate the spread of COVID-19: a systematic review. BMC Public Health. 2021 May 29;21(1):1015. pmid:34051769
70. Aden TA, Blevins P, York SW, Rager S, Hutson DBCL, Lowe D, et al. Rapid Diagnostic Testing for Response to the Monkeypox Outbreak—Laboratory Response. Network. 2022(71):904–907.